Article Details

Syros Pharmaceuticals (NASDAQ:SYRS) Downgraded by ValuEngine to “Sell”

Retrieved on: 2018-06-26 19:36:57

Tags for this article:

Click the tags to see associated articles and topics

Syros Pharmaceuticals (NASDAQ:SYRS) Downgraded by ValuEngine to “Sell”. View article details on hiswai:

Excerpt

<div>Finally, <b>Two Sigma Investments</b> LP increased its position in shares of Syros Pharmaceuticals by 80.3% in the 4th quarter. <b>Two Sigma Investments</b> LP ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo